ERS Genomics Unveils Early Access Express License for Innovators ERS Genomics has introduced its Early Access Express License to provide founders and teams affordable access to CRISPR/Cas9 technology for research purposes.

ERS Genomics Unveils Early Access Express License for Innovators #Ireland #Dublin #Gene_Editing #CRISPR #ERS_Genomics

ERS Genomics and Dyadic BioSolutions Forge Key CRISPR/Cas9 Licensing Agreement to Propel Biotech Innovations ERS Genomics and Dyadic BioSolutions team up through a CRISPR/Cas9 license agreement to enhance biotech product development and engineering capabilities.

ERS Genomics and Dyadic BioSolutions Forge Key CRISPR/Cas9 Licensing Agreement to Propel Biotech Innovations #Ireland #Dublin #CRISPR #ERS_Genomics #Dyadic

ERS Genomics Partners with Jumpcode to Enhance CRISPR Technology for Next-Generation Sequencing ERS Genomics and Jumpcode Genomics have formed a strategic alliance to utilize CRISPR/Cas9 technology, enhancing next-generation sequencing applications across various fields.

ERS Genomics Partners with Jumpcode to Enhance CRISPR Technology for Next-Generation Sequencing #United_States #San_Diego #CRISPR_Technology #ERS_Genomics #Jumpcode_Genomics

ERS Genomics Secures Major CRISPR Patent from European Patent Office, Strengthening Its Position in Biotechnology ERS Genomics celebrates the European Patent Office granting a significant CRISPR patent, reinforcing its leadership in the biotechnology landscape and boosting confidence for its licensees.

ERS Genomics Secures Major CRISPR Patent from European Patent Office, Strengthening Its Position in Biotechnology #Ireland #Dublin #biotechnology #CRISPR_Technology #ERS_Genomics